Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Trichostatin A

HDAC inhibitor
BML-GR309-0001 1 mg 156.00 USD
BML-GR309-0005 5 mg 517.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-380-068

Trichostatin A (TSA) is a potent and reversible inhibitor of histone deacetylases. In HeLa cells, TSA blocked cell cycle progression at G1 and induced a 12-fold increase in intracellular levels of gelsolin. In cells latently infected with HIV-1, TSA induced the transcriptional activation of the HIV-1 promoter, which resulted in a marked increase in virus production. In NIH 3T3 cells, TSA induced reversion of oncogenic ras-transformed cells to a normal morphology. In Jurkat cells, TSA inhibited IL-2 gene expression (IC50=73nM) and displayed immunosuppressive activity in a mouse model.

Induces increased acetylation of GATA4, a cardiac-specific transcription factor and increases cardiac muscle cell differentiation. Trichostatin A is a useful tool for induction of hyperacetylation of cellular histones and for further elucidation of their role in gene expression. Induces cell growth arrest at both G1 and G2/M phases. may induce apoptosis in some cases. It can induce accelerated dedifferentiation of primordial germ cells into embryonic germ cells.

Product Specification

Alternative Name:[R-(E,E)]-7-[4-(Dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxo-2,4-heptadienamide
Source:Isolated from Streptomyces platensis.
Purity:≥98% (HPLC)
Appearance:Off-white to beige solid.
Solubility:Soluble in DMSO, dimethyl formamide, acetonitrile, methanol or 100% ethanol
Long Term Storage:-20┬░C
Use/Stability:Store, as supplied, at -20°C for up to 1 year. Store solutions at -20°C for up to 3 months.
Please mouse over

Product Literature References

Identification of novel pathways and molecules able to down-regulate PHOX2B gene expression by in vitro drug screening approaches in neuroblastoma cells: E. Di Zanni, et al.; Exp. Cell Res. 336, 43 (2015), Application(s): Cell Culture, Abstract;
Inhibitors of histone deacetylases: correlation between isoform specificity and reactivation of HIV type 1 (HIV-1) from latently infected cells: K. Huber, et al.; J. Biol. Chem. 286, 22211 (2011), Abstract; Full Text
Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow: S. Snykers et al.; BMC Dev. Biol. 7, 24 (2007), Abstract;
Trichostatin A induces myocardial differentiation of monkey ES cells: M. Hosseinkhani et al.; Biochem. Biophys. Res. Commun. 356, 386 (2007), Abstract;
The NAD+ precursor nicotinic acid improves genomic integrity in human peripheral blood mononuclear cells after X-irradiation: K. Weidele, et al.; DNA Repair 52, 12 (20017), Abstract;
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo: D.M. Vigushin; Clin. Cancer Res. 7, 971 (2001), Abstract;
Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells: P.A. Marks et al.; J. Natl. Cancer Inst. 92, 1210 (2000), Abstract;
Regulation of the human O(6)-methylguanine-DNA methyltransferase gene by transcriptional coactivators cAMP response element-binding protein-binding protein and p300: K.K. Bhakat & S. Mitra; J. Biol. Chem. 275, 34197 (2000), Abstract;
Effects of cell density and trichostatin A on the expression of HDAC1 and p57Kip2 in Hep 3B cells: S.G. Gray et al.; Biochem. Biophys. Res. Commun. 245, 423 (1998), Abstract;
Retinoblastoma protein recruits histone deacetylase to repress transcription: A. Behm et al.; Nature 391, 597 (1998), Abstract;
A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells: S. Miucci et al.; PNAS 94, 11295 (1997), Abstract;
Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites: Y. Sowa et al.; Biochem. Biophys. Res. Commun. 241, 142 (1997), Abstract;
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway: V. Medina et al.; Cancer Res. 57, 3697 (1997), Abstract;
A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p: J. Taunton et al; Science 272, 408 (1996), Abstract;
Selective inhibition of IL-2 gene expression by trichostatin A, a potent inhibitor of mammalian histone deacetylase: I. Takahashi et al.; J. Antibiot. (Tokyo) 49, 453 (1996), Abstract;
Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation: C. Van Lint et al.; EMBO J. 15, 1112 (1996), Abstract;
Trichostatin A and trapoxin: novel chemical probes for the role of histone acetylation in chromatin structure and function: M. Yoshida et al.; Bioessays 17, 423 (1995), Abstract;
Trichostatin A inhibits both ras-induced neurite outgrowth of PC12 cells and morphological transformation of NIH3T3 cells: M. Futamura et al.; Oncogene 10, 1119 (1995), Abstract;
Trichostatin A induces morphological changes and gelsolin expression by inhibiting histone deacetylase in human carcinoma cell lines: Y. Hoshikawa et al.; Exp. Cell Res., 214, 189 (1994), Abstract;
Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A: M. Yoshida et al.; J. Biol. Chem. 265, 17174 (1990), Abstract;
A new antifungal antibiotic, trichostatin: N. Tsuji et al.; J. Antibiot. (Tokyo) 29, 1 (1976), Abstract;

Related Literature

Stem Cells
Stem Cells
Download as PDF

Download as PDF

Diabetes Catalog
Diabetes Catalog
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,